title: Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents.
abstract: Administration of ghrelin, an endogenous ligand for the GH secretagogue receptor 1a (GHSR 1a), induces potent stimulating effects on GH secretion and food intake. However, more than 7 yr after its discovery, the role of endogenous ghrelin remains elusive. Recently, a second peptide, obestatin, also generated from proteolytic cleavage of preproghrelin has been identified. This peptide inhibits food intake and gastrointestinal motility but does not modify in vitro GH release from pituitary cells. In this study, we have reinvestigated obestatin functions by measuring plasma ghrelin and obestatin levels in a period of spontaneous feeding in ad libitum-fed and 24-h fasted mice. Whereas fasting resulted in elevated ghrelin levels, obestatin levels were significantly reduced. Exogenous obestatin per se did not modify food intake in fasted and fed mice. However, it inhibited ghrelin orexigenic effect that were evident in fed mice only. The effects of obestatin on GH secretion were monitored in superfused pituitary explants and in freely moving rats. Obestatin was only effective in vivo to inhibit ghrelin stimulation of GH levels. Finally, the relationship between octanoylated ghrelin, obestatin, and GH secretions was evaluated by iterative blood sampling every 20 min during 6 h in freely moving adult male rats. The half-life of exogenous obestatin (10 microg iv) in plasma was about 22 min. Plasma obestatin levels exhibited an ultradian pulsatility with a frequency slightly lower than octanoylated ghrelin and GH. Ghrelin and obestatin levels were not strictly correlated. In conclusion, these results show that obestatin, like ghrelin, is secreted in a pulsatile manner and that in some conditions; obestatin can modulate exogenous ghrelin action. It remains to be determined whether obestatin modulates endogenous ghrelin actions.
authors.affiliation: Unité Mixte de Recherche, 549 Institut National de la Santé et de la Recherche Médicale, Faculté de Médecine, Université Paris-Descartes, Paris, France. philippe.zizzari@broca.inserm.fr
authors.forename: Philippe
authors.initials: P
authors.lastname: Zizzari
authors.forename: Romaine
authors.initials: R
authors.lastname: Longchamps
authors.forename: Jacques
authors.initials: J
authors.lastname: Epelbaum
authors.forename: Marie Thérèse
authors.initials: MT
authors.lastname: Bluet-Pajot
mesh_terms: D000818:Animals; D004435:Eating / Q000187:drug effects*; D005215:Fasting; D054439:Ghrelin; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D036361:Peptide Hormones / Q000097:blood / Q000494:pharmacology* / Q000502:physiology; D017440:Photoperiod; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D054439:Ghrelin; D036361:Peptide Hormones; C512328:obestatin, mouse; D013006:Growth Hormone